Abstract
In this work we aimed at finding a concise method for the design of the new pharmacologically active compound 6, which is a precursor to obtaining non-protein amino acid 7 considered as GABA analogue, furthermore it can be used to construct enantiopure, conformationally restricted peptides. For this purpose the Schmidt reaction was applied.
Keywords: Amino acids, schmidt reaction, natural products, terpenoids
Letters in Organic Chemistry
Title: Concise Synthesis of Non-Protein Amino Acid from Natural Product via Schmidt Reaction
Volume: 6 Issue: 3
Author(s): Kamila Gajcy, Tadeusz Librowski and Stanislaw Lochynski
Affiliation:
Keywords: Amino acids, schmidt reaction, natural products, terpenoids
Abstract: In this work we aimed at finding a concise method for the design of the new pharmacologically active compound 6, which is a precursor to obtaining non-protein amino acid 7 considered as GABA analogue, furthermore it can be used to construct enantiopure, conformationally restricted peptides. For this purpose the Schmidt reaction was applied.
Export Options
About this article
Cite this article as:
Gajcy Kamila, Librowski Tadeusz and Lochynski Stanislaw, Concise Synthesis of Non-Protein Amino Acid from Natural Product via Schmidt Reaction, Letters in Organic Chemistry 2009; 6 (3) . https://dx.doi.org/10.2174/157017809787893037
DOI https://dx.doi.org/10.2174/157017809787893037 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exploring the Chemistry and Therapeutic Potential of Triazoles: A Comprehensive Literature Review
Mini-Reviews in Medicinal Chemistry Assessment and Imaging of the Cerebrovascular Glycocalyx
Current Neurovascular Research Discovery of Substituted N-(6-Chloro-3-cyano-4-phenyl-4H-chromen-2-yl)- 2-(4-chloro-phenoxy)-acetamide for Biphasic Anticancer and Anticonvulsant Activities
Medicinal Chemistry Expression and Function of Cytochrome P450 in Brain Drug Metabolism
Current Drug Metabolism Kappa Receptor Bivalent Ligands
Current Topics in Medicinal Chemistry Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca<sup>2+</sup> Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
CNS & Neurological Disorders - Drug Targets Drugs, Environmental Factors, Loci and Genes Involved in Nonsyndromic Orofacial Cleft
Current Pharmacogenomics Potential Interaction Between Valproic Acid and Doripenem
Current Drug Safety From A1 to A3 en passant Through A2A Receptors in the Hippocampus: Pharmacological Implications
CNS & Neurological Disorders - Drug Targets Gamma-Decanolactone Improves Biochemical Parameters Associated with Pilocarpine-Induced Seizures in Male Mice
Current Molecular Pharmacology Computational Studies of Molecular Targets Regarding the Adverse Effects of Isoniazid Drug for Tuberculosis
Current Pharmacogenomics and Personalized Medicine Ketamine: New Indications for an Old Drug
Current Drug Targets Microglia Phenotype Diversity
CNS & Neurological Disorders - Drug Targets Rational Drug Development Using Gene-Targeted Agents and Their Application in Anti-Gene Radiotherapy
Current Genomics Editorial [Hot Topic: Recent Developments in the Drug Discovery of Epilepsy (Guest Editor: Waquar Ahsan)]
Current Topics in Medicinal Chemistry Schiff Bases of Benzothiazol-2-ylamine and Thiazolo[5,4-b] pyridin-2-ylamine as Anticonvulsants: Synthesis, Characterization and Toxicity Profiling*
Central Nervous System Agents in Medicinal Chemistry Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Targeting the Role of Astrocytes in the Progression of Alzheimers Disease
Current Signal Transduction Therapy Epilepsy, Comorbidities and Treatments
Current Pharmaceutical Design Differences in Functional Brain Activation and Hippocampal Volume Among Amnestic Mild Cognitive Impairment Subtypes
Current Alzheimer Research